학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 5,495건 | 목록 1~20
Academic Journal
16 Problema. Anuario de Filosofia y Teoria del Derecho (PAFTD) 389 (2022) / Problema. Anuario de Filosofia y Teoria del Derecho (PAFTD), Vol. 16, pp. 389-398
Academic Journal
Negishi H; Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. hnegishi@ims.u-tokyo.ac.jp.; International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. hnegishi@ims.u-tokyo.ac.jp.; Laboratory of Immunology and Infection Control, Institute for Quantitative Biosciences, The University of Tokyo, Tokyo, Japan. hnegishi@ims.u-tokyo.ac.jp.; The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center (UTOPIA), The University of Tokyo, Tokyo, Japan. hnegishi@ims.u-tokyo.ac.jp.; Wada Y; Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Shirasaki Y; Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan.; Hayashi T; Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center (UTOPIA), The University of Tokyo, Tokyo, Japan.; Kubota Y; Division of Cell Signaling and Molecular Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Iwasaki T; Research and Development Group, Hitachi, Ltd., Ibaraki, Japan.; Kurosawa M; Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Ban T; Department of Immunology, Yokohama City University Graduate School of Medicine, Kanagawa, Japan.; Muto D; Laboratory of Evolutionary Oncology, Chiba Cancer Center Research Institute, Chiba, Japan.; Graduate School of Medical and Pharmaceutical Sciences, Chiba University, Chiba, Japan.; Suenaga Y; Laboratory of Evolutionary Oncology, Chiba Cancer Center Research Institute, Chiba, Japan.; Kojima T; Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Matsuda Y; Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Irish SL; Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Dodo K; Synthetic Organic Chemistry Laboratory, RIKEN Cluster for Pioneering Research, Saitama, Japan.; Catalysis and Integrated Research Group, RIKEN Center for Sustainable Resource Science, Saitama, Japan.; Suzuki T; Division of RNA and gene regulation, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Yamagishi M; Live Cell Diagnosis, Ltd., Saitama, Japan.; Temizoz B; Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center (UTOPIA), The University of Tokyo, Tokyo, Japan.; Yoshimori A; Institute for Theoretical Medicine, Inc., Kanagawa, Japan.; Kanai C; INTAGE Healthcare, Inc., Osaka, Japan.; Nagasaki Y; Department of Infectious Diseases, NHO Kyushu Medical Center, Fukuoka, Japan.; Ohmuraya M; Department of Genetics, School of Medicine, Hyogo Medical University, Hyogo, Japan.; Tamura T; Department of Immunology, Yokohama City University Graduate School of Medicine, Kanagawa, Japan.; Advanced Medical Research Center, Yokohama City University, Kanagawa, Japan.; Iwama A; The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center (UTOPIA), The University of Tokyo, Tokyo, Japan.; Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Laboratory of Cellular and Molecular Chemistry, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan.; Inada T; The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center (UTOPIA), The University of Tokyo, Tokyo, Japan.; Division of RNA and gene regulation, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Kuroda E; Department of Immunology, Hyogo Medical University School of Medicine, Hyogo, Japan.; Kobiyama K; Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center (UTOPIA), The University of Tokyo, Tokyo, Japan.; Division of Rheumatology, Department of medicine, University of California San Diego, La Jolla, CA, USA.; Toyama-Sorimachi N; International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Takekawa M; The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center (UTOPIA), The University of Tokyo, Tokyo, Japan.; Division of Cell Signaling and Molecular Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Medical Proteomics Laboratory, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Coban C; International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center (UTOPIA), The University of Tokyo, Tokyo, Japan.; Division of Malaria Immunology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Ishii KJ; Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. kenishii@ims.u-tokyo.ac.jp.; International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. kenishii@ims.u-tokyo.ac.jp.; The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center (UTOPIA), The University of Tokyo, Tokyo, Japan. kenishii@ims.u-tokyo.ac.jp.; Laboratory of Vaccine Science, WPI Immunology Frontier Research Center, Osaka University, Osaka, Japan. kenishii@ims.u-tokyo.ac.jp.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Academic Journal
Ando M; Department of Respiratory Medicine, Oita Prefectural Hospital, Japan.; Nagase H; Department of Respiratory Medicine, Oita Prefectural Hospital, Japan.; Shibata T; Department of Respiratory Medicine, Oita Prefectural Hospital, Japan.; Yamatani I; Department of Respiratory Medicine, Oita Prefectural Hospital, Japan.; Kan T; Department of Respiratory Medicine, Oita Prefectural Hospital, Japan.; Omote E; Department of Respiratory Medicine, Oita Prefectural Hospital, Japan.; Suenaga Y; Department of Nephrology, Oita Prefectural Hospital, Japan.; Fukunaga N; Department of Nephrology, Oita Prefectural Hospital, Japan.; Katafuchi E; Department of Pathology, School of Medicine, University of Occupational and Environmental Health, Japan.; Nakayama T; Department of Pathology, School of Medicine, University of Occupational and Environmental Health, Japan.; Komiya K; Department of Respiratory Medicine and Infection Diseases, Oita University Faculty of Medicine, Japan.
Publisher: Japanese Society of Internal Medicine Country of Publication: Japan NLM ID: 9204241 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1349-7235 (Electronic) Linking ISSN: 09182918 NLM ISO Abbreviation: Intern Med Subsets: MEDLINE
Editorial & Opinion
Zhu Y; Department of Urology, The First Hospital of China Medical University, Shenyang, China.; Suenaga Y; Laboratory of Evolutionary Oncology, Chiba Cancer Center Research Institute, Chiba, Japan.
Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Academic Journal
Lestari B; Department Pharmacology and Therapy, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, 55281, Indonesia.; Cancer Chemoprevention Research Center, Faculty of Pharmacy, Universitas Gadjah Mada, Sekip Utara, Sleman, Yogyakarta, 55281, Indonesia.; Utomo RY; Cancer Chemoprevention Research Center, Faculty of Pharmacy, Universitas Gadjah Mada, Sekip Utara, Sleman, Yogyakarta, 55281, Indonesia. rohmad.yudi.utomo@ugm.ac.id.; Laboratory of Medicinal Chemistry, Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Universitas Gadjah Mada, Sekip Utara, Sleman, Yogyakarta, 55281, Indonesia. rohmad.yudi.utomo@ugm.ac.id.; Rahman FA; Cancer Chemoprevention Research Center, Faculty of Pharmacy, Universitas Gadjah Mada, Sekip Utara, Sleman, Yogyakarta, 55281, Indonesia.; Putri DDP; Cancer Chemoprevention Research Center, Faculty of Pharmacy, Universitas Gadjah Mada, Sekip Utara, Sleman, Yogyakarta, 55281, Indonesia.; Laboratory of Pharmacology and Toxicology, Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Gadjah Mada, Sekip Utara, Sleman, Yogyakarta, 55281, Indonesia.; Zulfin UM; Cancer Chemoprevention Research Center, Faculty of Pharmacy, Universitas Gadjah Mada, Sekip Utara, Sleman, Yogyakarta, 55281, Indonesia.; Laboratory of Evolutionary Oncology, Chiba Cancer Centre Research Institute, Chiba, 260-0801, Japan.; Suenaga Y; Laboratory of Evolutionary Oncology, Chiba Cancer Centre Research Institute, Chiba, 260-0801, Japan.; Meiyanto E; Cancer Chemoprevention Research Center, Faculty of Pharmacy, Universitas Gadjah Mada, Sekip Utara, Sleman, Yogyakarta, 55281, Indonesia.; Laboratory of Macromolecular Engineering, Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Universitas Gadjah Mada, Sekip Utara, Sleman, Yogyakarta, 55281, Indonesia.; Hippo Y; Laboratory of Evolutionary Oncology, Chiba Cancer Centre Research Institute, Chiba, 260-0801, Japan.; Laboratory of Precision Tumor Model Systems, Chiba Cancer Centre Research Institute, Chiba, 260-0801, Japan.
Publisher: BioMed Central Country of Publication: England NLM ID: 101761232 Publication Model: Electronic Cited Medium: Internet ISSN: 2662-7671 (Electronic) Linking ISSN: 26627671 NLM ISO Abbreviation: BMC Complement Med Ther Subsets: MEDLINE
Academic Journal
Qin XY; Laboratory for Cellular Function Conversion Technology, RIKEN Center for Integrative Medical Sciences, Yokohama, Kanagawa 230-0045, Japan.; Xu Y; Laboratory for Cellular Function Conversion Technology, RIKEN Center for Integrative Medical Sciences, Yokohama, Kanagawa 230-0045, Japan.; Mishra H; Laboratory for Cellular Function Conversion Technology, RIKEN Center for Integrative Medical Sciences, Yokohama, Kanagawa 230-0045, Japan.; Shirakami Y; Department of Gastroenterology, Graduate School of Medicine, Gifu University, Gifu 501-1194, Japan.; Yeh SH; Department of Microbiology, National Taiwan University College of Medicine, Taipei 100, Taiwan.; Li CL; Department of Microbiology, National Taiwan University College of Medicine, Taipei 100, Taiwan.; Numata K; Gastroenterological Center, Yokohama City University Medical Center, Yokohama, Kanagawa 232-0024, Japan.; Suenaga Y; Laboratory of Evolutionary Oncology, Chiba Cancer Center Research Institute, Chiba 260-8717, Japan.; Wei F; Division of Cancer Immunotherapy, Kanagawa Cancer Center Research Institute, Yokohama, Kanagawa 241-8515, Japan.; Ando R; Support Unit for Bio-Material Analysis, Research Resources Division, RIKEN Center for Brain Science, Wako, Saitama 351-0198, Japan.; Nishimura H; Laboratory for Cellular Function Conversion Technology, RIKEN Center for Integrative Medical Sciences, Yokohama, Kanagawa 230-0045, Japan.; Furuhata E; Laboratory for Cellular Function Conversion Technology, RIKEN Center for Integrative Medical Sciences, Yokohama, Kanagawa 230-0045, Japan.; Maeda S; Laboratory for Cellular Function Conversion Technology, RIKEN Center for Integrative Medical Sciences, Yokohama, Kanagawa 230-0045, Japan.; Furutani Y; Department of Laboratory Medicine, The Jikei University School of Medicine, Tokyo 105-8461, Japan.; Yanaka K; Department of Laboratory Medicine, The Jikei University School of Medicine, Tokyo 105-8461, Japan.; Yamamoto M; Department of Tumor Pathology, Graduate School of Health Sciences, Kumamoto University, Kumamoto 862-0976, Japan.; Goto M; Division of Tumor Pathology, Department of Pathology, Asahikawa Medical University, Asahikawa, Hokkaido 078-8510, Japan.; Takasawa A; Division of Tumor Pathology, Department of Pathology, Asahikawa Medical University, Asahikawa, Hokkaido 078-8510, Japan.; Nishikawa Y; Division of Tumor Pathology, Department of Pathology, Asahikawa Medical University, Asahikawa, Hokkaido 078-8510, Japan.; Tomita H; Department of Tumor Pathology, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan.; Center for One Medicine Innovative Translational Research, Gifu University Institute for Advanced Study, Gifu 501-1194, Japan.; Gailhouste L; Laboratory for Brain Development and Disorders, RIKEN Center for Brain Science, Wako, Saitama 351-0198, Japan.; Matsuura T; Department of Laboratory Medicine, The Jikei University School of Medicine, Tokyo 105-8461, Japan.; Chen PJ; Graduate Institute of Clinical Medicine, Department of Internal Medicine, National Taiwan University College of Medicine and Hospital, Taipei 100, Taiwan.; Shimizu M; Department of Gastroenterology, Graduate School of Medicine, Gifu University, Gifu 501-1194, Japan.; Hippo Y; Laboratory of Evolutionary Oncology, Chiba Cancer Center Research Institute, Chiba 260-8717, Japan.; Suzuki H; Laboratory for Cellular Function Conversion Technology, RIKEN Center for Integrative Medical Sciences, Yokohama, Kanagawa 230-0045, Japan.
Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1091-6490 (Electronic) Linking ISSN: 00278424 NLM ISO Abbreviation: Proc Natl Acad Sci U S A Subsets: MEDLINE
Academic Journal
Xu Y; Laboratory for Cellular Function Conversion Technology, RIKEN Center for Integrative Medical Sciences, Tsurumi-ku, Yokohama 2300045, Japan.; Department of Intensive Care Unit, The Affiliated Drum Tower Hospital, Medical School of Nanjing University, Gulou, Nanjing 210008, China.; Mishra H; Laboratory for Cellular Function Conversion Technology, RIKEN Center for Integrative Medical Sciences, Tsurumi-ku, Yokohama 2300045, Japan.; Osada H; RIKEN Center for Sustainable Resource Science, Hirosawa, Wako 3510198, Japan.; Institute of Microbial Chemistry (BIKAKEN), Shinagawa-ku, Tokyo 1410021, Japan.; Watanabe N; RIKEN Center for Sustainable Resource Science, Hirosawa, Wako 3510198, Japan.; Hirano H; RIKEN Center for Sustainable Resource Science, Hirosawa, Wako 3510198, Japan.; Nishimura H; Laboratory for Cellular Function Conversion Technology, RIKEN Center for Integrative Medical Sciences, Tsurumi-ku, Yokohama 2300045, Japan.; Furutani Y; Department of Laboratory Medicine, The Jikei University School of Medicine, Minato-ku, Tokyo 1058461, Japan.; Suenaga Y; Laboratory of Evolutionary Oncology, Chiba Cancer Center Research Institute;, Chuo-ku, Chiba 2608717, Japan.; Hippo Y; Laboratory of Evolutionary Oncology, Chiba Cancer Center Research Institute;, Chuo-ku, Chiba 2608717, Japan.; Yu W; Department of Intensive Care Unit, The Affiliated Drum Tower Hospital, Medical School of Nanjing University, Gulou, Nanjing 210008, China.; Suzuki H; Laboratory for Cellular Function Conversion Technology, RIKEN Center for Integrative Medical Sciences, Tsurumi-ku, Yokohama 2300045, Japan.; Qin XY; Laboratory for Cellular Function Conversion Technology, RIKEN Center for Integrative Medical Sciences, Tsurumi-ku, Yokohama 2300045, Japan.
Publisher: American Chemical Society Country of Publication: United States NLM ID: 101282906 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1554-8937 (Electronic) Linking ISSN: 15548929 NLM ISO Abbreviation: ACS Chem Biol Subsets: MEDLINE
Academic Journal
Tatsumi Y; Division of Molecular Carcinogenesis, Chiba Cancer Center Research Institute, Chiba 260‑8717, Japan.; Masuda T; Division of Molecular Carcinogenesis, Chiba Cancer Center Research Institute, Chiba 260‑8717, Japan.; Watanabe T; Division of Molecular Carcinogenesis, Chiba Cancer Center Research Institute, Chiba 260‑8717, Japan.; Utomo RY; Macromolecular Engineering Laboratory, Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta 55281, Indonesia.; Zulfin UM; Macromolecular Engineering Laboratory, Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta 55281, Indonesia.; Meiyanto E; Macromolecular Engineering Laboratory, Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta 55281, Indonesia.; Ozaki T; Division of Molecular Carcinogenesis, Chiba Cancer Center Research Institute, Chiba 260‑8717, Japan.; Suenaga Y; Laboratory of Evolutionary Oncology, Chiba Cancer Center Research Institute, Chiba 260‑8717, Japan.; Kamikubo Y; Division of Molecular Carcinogenesis, Chiba Cancer Center Research Institute, Chiba 260‑8717, Japan.
Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9422756 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1791-2431 (Electronic) Linking ISSN: 1021335X NLM ISO Abbreviation: Oncol Rep Subsets: MEDLINE
Conference
18th International Conference on Pattern Recognition (ICPR'06) Pattern Recognition, 2006. ICPR 2006. 18th International Conference on. 3:288-291 2006
Academic Journal
Xu Y; Laboratory for Cellular Function Conversion Technology, RIKEN Center for Integrative Medical Sciences, Kanagawa, Yokohama, Japan.; Department of Intensive Care Unit, The Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, Jiangsu, China.; Mishra H; Laboratory for Cellular Function Conversion Technology, RIKEN Center for Integrative Medical Sciences, Kanagawa, Yokohama, Japan.; Furutani Y; Department of Laboratory Medicine, The Jikei University School of Medicine, Tokyo, Japan.; Yanaka K; Department of Laboratory Medicine, The Jikei University School of Medicine, Tokyo, Japan.; Nishimura H; Laboratory for Cellular Function Conversion Technology, RIKEN Center for Integrative Medical Sciences, Kanagawa, Yokohama, Japan.; Furuhata E; Laboratory for Cellular Function Conversion Technology, RIKEN Center for Integrative Medical Sciences, Kanagawa, Yokohama, Japan.; Takahashi M; Laboratory for Cellular Function Conversion Technology, RIKEN Center for Integrative Medical Sciences, Kanagawa, Yokohama, Japan.; Gailhouste L; Laboratory for Brain Development and Disorders, RIKEN Center for Brain Science, Saitama, Japan.; Suenaga Y; Laboratory of Evolutionary Oncology, Chiba Cancer Center Research Institute, Chiba, Japan.; Hippo Y; Laboratory of Evolutionary Oncology, Chiba Cancer Center Research Institute, Chiba, Japan.; Yu W; Department of Intensive Care Unit, The Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, Jiangsu, China.; Matsuura T; Department of Laboratory Medicine, The Jikei University School of Medicine, Tokyo, Japan.; Suzuki H; Laboratory for Cellular Function Conversion Technology, RIKEN Center for Integrative Medical Sciences, Kanagawa, Yokohama, Japan.; Qin XY; Laboratory for Cellular Function Conversion Technology, RIKEN Center for Integrative Medical Sciences, Kanagawa, Yokohama, Japan.
Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Academic Journal
Matsushita K; Department of Laboratory Medicine, Chiba University Hospital, Chiba 260-8677, Japan.; Kitamura K; Department of Laboratory Medicine, Chiba University Hospital, Chiba 260-8677, Japan.; Tanaka N; Department of Laboratory Medicine, Chiba University Hospital, Chiba 260-8677, Japan.; Kobayashi S; Department of Medical Technology and Sciences, Health and Sciences, International University of Health and Welfare, Chiba 286-8686, Japan.; Suenaga Y; Laboratory of Evolutionary Oncology, Chiba Cancer Center Research Institute, Chiba 260-8717, Japan.; Hoshino T; Department of Molecular Design, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba 260-8675, Japan.
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE
Conference
Proceedings of the 17th International Conference on Pattern Recognition, 2004. ICPR 2004. Pattern recognition Pattern Recognition, 2004. ICPR 2004. Proceedings of the 17th International Conference on. 3:322-325 Vol.3 2004
Conference
Proceedings of the 17th International Conference on Pattern Recognition, 2004. ICPR 2004. Pattern recognition Pattern Recognition, 2004. ICPR 2004. Proceedings of the 17th International Conference on. 2:630-633 Vol.2 2004
Academic Journal
Utomo RY; Cancer Chemoprevention Research Center, Faculty of Pharmacy, Universitas Gadjah Mada, Sleman, Yogyakarta, Indonesia. rohmad.yudi.utomo@ugm.ac.id.; Laboratory of Medicinal Chemistry, Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Universitas Gadjah Mada, Sleman, Yogyakarta, Indonesia. rohmad.yudi.utomo@ugm.ac.id.; Hapsari NP; Cancer Chemoprevention Research Center, Faculty of Pharmacy, Universitas Gadjah Mada, Sleman, Yogyakarta, Indonesia.; Nugraheni N; Cancer Chemoprevention Research Center, Faculty of Pharmacy, Universitas Gadjah Mada, Sleman, Yogyakarta, Indonesia.; Lestari B; Department Pharmacology and Therapy, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia.; Hanifa M; Cancer Chemoprevention Research Center, Faculty of Pharmacy, Universitas Gadjah Mada, Sleman, Yogyakarta, Indonesia.; Linda Laksmiani NP; Cancer Chemoprevention Research Center, Faculty of Pharmacy, Universitas Gadjah Mada, Sleman, Yogyakarta, Indonesia.; Department of Pharmacy, Faculty of Mathematics and Natural Science, Udayana University, Badung, Bali, Indonesia.; Zulfin UM; Cancer Chemoprevention Research Center, Faculty of Pharmacy, Universitas Gadjah Mada, Sleman, Yogyakarta, Indonesia.; Laboratory of Evolutionary Oncology, Chiba Cancer Center Research Institute, Chiba, Japan.; Muto D; Laboratory of Evolutionary Oncology, Chiba Cancer Center Research Institute, Chiba, Japan.; Graduate School of Medical and Pharmaceutical Sciences, Chiba University, Chiba, Japan.; Innovative Medicine CHIBA Doctoral WISE Program, Chiba University, Chiba, Japan.; All Directional Innovation Creator Ph.D. Project, Chiba University, Chiba, Japan.; Ikawati M; Cancer Chemoprevention Research Center, Faculty of Pharmacy, Universitas Gadjah Mada, Sleman, Yogyakarta, Indonesia.; Laboratory of Macromolecular Engineering, Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Universitas Gadjah Mada, Sleman, Yogyakarta, Indonesia.; Suenaga Y; Laboratory of Evolutionary Oncology, Chiba Cancer Center Research Institute, Chiba, Japan.; Hippo Y; Department Pharmacology and Therapy, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia.; Department of Molecular Carcinogenesis, Chiba Cancer Center Research Institute, Chiba, Japan.; Meiyanto E; Laboratory of Macromolecular Engineering, Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Universitas Gadjah Mada, Sleman, Yogyakarta, Indonesia.; Jenie RI; Cancer Chemoprevention Research Center, Faculty of Pharmacy, Universitas Gadjah Mada, Sleman, Yogyakarta, Indonesia. riris_jenie@ugm.ac.id.; Laboratory of Macromolecular Engineering, Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Universitas Gadjah Mada, Sleman, Yogyakarta, Indonesia. riris_jenie@ugm.ac.id.
Publisher: Springer Country of Publication: United States NLM ID: 9435512 Publication Model: Electronic Cited Medium: Internet ISSN: 1559-131X (Electronic) Linking ISSN: 13570560 NLM ISO Abbreviation: Med Oncol Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Suenaga, Y.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어